Romantic Horror Thriller OTT: వెయ్యేళ్ల నాటి మిస్టరీ..ఒకరోజు ముందుగానే ఓటీటీలోకి తెలుగులో తమిళ రొమాంటిక్ హారర్ థ్రిల్లర్

భారతదేశం, అక్టోబర్ 29 -- Romantic Horror Thriller OTT: సాధారణంగా థియేటర్లలో సక్సెస్ అయిన సినిమాలు ఓటీటీలోకి ఎప్పుడెప్పుడు వస్తాయా అని సినీ అభిమానులు ఆసక్తిగా ఎదురుచూస్తుంటారు. అలాంటి వారికి 'ఇమ్మోర్టల... Read More

IPO Opening Announcement of Vectras Enprocon Limited on BSE SME Platform

New Delhi, Oct. 29 -- Ahmedabad (Gujarat) [India], October 29: Vectras Enprocon Limited , a Gujarat-based Integrated solution provider in critical midstream and downstream infrastructure for th... Read More

Credo Brands Marketing to hold board meeting

Mumbai, Oct. 29 -- Credo Brands Marketing will hold a meeting of the Board of Directors of the Company on 4 November 2026. Published by HT Digital Content Services with permission from Capital Market... Read More

iQOO Neo 12 : 9000ఎంఏహెచ్​ బ్యాటరీతో కొత్త గేమింగ్ స్మార్ట్​ఫోన్ లాంచ్- ఐక్యూ నియో 12 ధర, ఫీచర్లు..

భారతదేశం, అక్టోబర్ 29 -- స్మార్ట్‌ఫోన్ ప్రియులు, ముఖ్యంగా గేమింగ్ లవర్స్ ఎప్పుడెప్పుడా అని ఆసక్తిగా ఎదురుచూస్తున్న 'ఐక్యూ నియో 12' చైనా మార్కెట్​లోకి అధికారికంగా అడుగుపెట్టింది. గతంలో వచ్చి మంచి విజయా... Read More

Thakurgaon BNP candidate eyes big win

Dhaka, Oct. 29 -- BNP candidate Mirza Faisal Amin, the younger brother of President Mirza Fakhrul Islam Alamgir, has voiced hope of a big win in the Thakurgaon by-election. After casting his vote at ... Read More

Lee Kuan Yew Global Business Plan Competition Opens Global Search for Deep Tech Urban Solutions and Sustainability focused Founders

Bhubaneswar, Oct. 29 -- Finalists compete for over S$2.5 million (US$2 million) in prizes and gain a pathway to SMU's Urban SustaInnovator accelerator and US$10 million USI Fund Grand Finalists from ... Read More

SC refuses to order 'full public disclosure' of ultimate beneficiaries of AIFs, FPIs without 'legal framework'

New Delhi, Oct. 29 -- The Supreme Court on Thursday refused to direct the Securities and Exchange Board of India (SEBI) to mandate full public disclosure of the details of ultimate beneficial owners (... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

• ««
• «
• 288
• 289
• 290
• 291
• 292
• 293
• 294
• 295
• 296
• 297
• »
• »»